Nevrološki zapleti zdravljenja z zaviralci imunskih nadzornih točk
Neurological adverse events of immune checkpoint inhibitors
case report
DOI:
https://doi.org/10.25670/oi2025-006onKeywords:
immune checkpoint inhibitors , drug toxicity, nervous system immune diseases , acute inflammatory demyelinating polyneuropathy , myositisAbstract
Pomembnemu ugodnemu učinku zdravljenja z zaviralci imunskih nadzornih točk so relativno pogosto pridruženi neželeni zapleti, med katerimi so nevrološki redki, a lahko življenje ogrožujoči.
V prispevku so predstavljeni nevrološki zapleti zdravljenja z
zaviralci imunskih nadzornih točk. Podana klinična primera
opišeta nevrološka zapleta s klinično sliko prizadetosti perifernega živčevja, in sicer miozitisom in akutno inflamatorno demielinizirajočo polinevropatijo.
Abstract (Eng)
The significant beneficial effect of treatment with immune checkpoint inhibitors is relatively often accompanied by adverse events, of which neurological events are rare but can be life-threatening.
The article presents neurological complications of treatment with immune checkpoint inhibitors. Two given clinical cases describe neurological adverse events with a clinical picture of peripheral nervous system involvement, namely myositis and acute inflammatory demyelinating polyneuropathy.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nadja Novak Bošnjak, aljoša Andlovic

This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is published under the terms of the Creative Commons Attribution License CC-BY 4.0. The authors retain the copyright to their work without any restrictions whatsoever.
This journal is an open-access journal, meaning that all of its contents are freely accessible without any charge to the user or their institution. In accordance with the Budapest Open Access Initiative (BOAI) definition of open access, users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking for prior permission from the publisher or the author, provided the authors and the journal are appropriately credited.








